Leidos Holdings, Inc. LDOS on Tuesday reported third-quarter fiscal 2024 revenue growth of 7% year-over-year to $4.19 billion, beating the analyst consensus estimate of $4.07 billion. Demand across all customer segments, especially for managed health services, drove the growth.
The defense, aviation, information technology, and biomedical research company's adjusted EPS was $2.93, up 44% year over year, beating the analyst consensus estimate of $2.02.
Adjusted net income was $396 million for the quarter, up 40% year-over-year.
Also Read: Leidos Wins $86M Contract to Enhance Geospatial Intelligence Systems for National Security
Adjusted EBITDA was $596 million, up 32% year over year. The margin of 14.2% increased from 11.5% a year ago.
Net bookings totaled $8.1 billion for the quarter, representing a book-to-bill ratio of 1.9. As a result, the backlog at the end of the year was $40.6 billion, of which $9.1 billion was funded.
Leidos held $1.19 billion in cash and equivalents as of Sept. 27.
Outlook: Leidos expects fiscal 2024 revenue of $16.35 billion–$16.45 billion (prior $16.1 billion–$16.4 billion). The analyst consensus stands at $16.3 billion.
The company expects its fiscal 2024 adjusted EPS of $9.80–$10.00 (prior $8.60–$9.00) versus the $9.08 consensus.
Leidos Holdings stock gained over 57% year-to-date.
Price Action: LDOS stock is up 8.7% at $184.50 at last check on Tuesday.
Also Read:
Photo: JHVEPhoto/Shutterstock.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
